<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id>
<journal-title>Frontiers in Neurology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Neurol.</abbrev-journal-title>
<issn pub-type="epub">1664-2295</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fneur.2024.1509655</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: The use of plasma exchange with albumin replacement in the management of Alzheimer&#x00027;s disease: a scoping review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name><surname>Cantero-Fortiz</surname> <given-names>Yahveth</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<xref ref-type="author-notes" rid="fn003"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2751851/overview"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Boada</surname> <given-names>Merc&#x000E8;</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
<xref ref-type="author-notes" rid="fn004"><sup>&#x02021;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/632451/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff>
<aff id="aff2"><sup>2</sup><institution>Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited and reviewed by: Iv&#x000E1;n Murrieta-&#x000C1;lvarez, Baylor College of Medicine, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Yahveth Cantero-Fortiz <email>ycantero&#x00040;fundacioace.org</email></corresp>
<fn fn-type="equal" id="fn002"><p>&#x02020;These authors have contributed equally to this work</p></fn>
<fn fn-type="other" id="fn003"><p>&#x02021;ORCID: Yahveth Cantero-Fortiz <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-0329-6487">orcid.org/0000-0003-0329-6487</ext-link></p></fn>
<fn fn-type="other" id="fn004"><p>Merc&#x000E8; Boada <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-2617-3009">orcid.org/0000-0003-2617-3009</ext-link></p></fn></author-notes>
<pub-date pub-type="epub">
<day>29</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1509655</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2024 Cantero-Fortiz and Boada.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Cantero-Fortiz and Boada</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Neurol." journal-id-type="nlm-ta" vol="15" page="1443132" xlink:href="10.3389/fneur.2024.1443132" ext-link-type="doi">A corrigendum on <article-title>The use of plasma exchange with albumin replacement in the management of Alzheimer&#x00027;s disease: a scoping review</article-title> by Cantero-Fortiz, Y., and Boada, M. (2024). <italic>Front. Neurol</italic>. 15:1443132. doi: <object-id>10.3389/fneur.2024.1443132</object-id></related-article>
<kwd-group>
<kwd>Alzheimer&#x00027;s disease</kwd>
<kwd>plasma exchange</kwd>
<kwd>albumin replacement</kwd>
<kwd>cognitive function</kwd>
<kwd>amyloid-beta</kwd>
<kwd>neurodegenerative disorders</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="0"/>
<page-count count="2"/>
<word-count count="564"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Dementia and Neurodegenerative Diseases</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In the published article, there was an error regarding the significance of the results using &#x0201C;<italic>p</italic> &#x0003C; 0.05&#x0201D; instead of &#x0201C;<italic>p</italic> &#x0003E; 0.05.&#x0201D; Despite the Clinical relevance, there was no statistical significance.</p>
<p>A correction has been made to the <bold>Results</bold> section, subsection <italic>Neuropsychological and quality-of-life section assessments</italic>, paragraph 26. The sentence originally stated:</p>
<p>&#x0201C;The study employed standardized tests such as the Mini-Mental State Examination (MMSE) and the AD Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) which showed statistically significant improvements (p &#x0003C; 0.05) in the treatment group over the 21 weeks treatment period plus 6 months follow-up.&#x0201D;</p>
<p>The correct sentence should be:</p>
<p>&#x0201C;The study employed standardized tests such as the Mini-Mental State Examination (MMSE) and the Alzheimer&#x00027;s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) which demonstrated clinical improvements in the treatment group. However, these improvements did not reach statistical significance (<italic>p</italic> &#x0003E; 0.05) over the 21-week treatment period plus 6 months of follow-up.&#x0201D;</p>
<p>Additionally, the term &#x0201C;AD disease&#x0201D; was used redundantly in several paragraphs.</p>
<p>A correction has been made throughout the article, [Paragraphs 11, 12, 14, 20, 21, 22, 26, and 35]. These sentences previously stated:</p>
<p>&#x0201C;AD disease&#x0201D;</p>
<p>The corrected sentences now state:</p>
<p>&#x0201C;AD&#x0201D;</p>
<p>The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
<back>
<sec sec-type="disclaimer" id="s1">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>